Alector, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
Alector, Inc. (ALEC) reported Revenue from Contract with Customer, Excluding Assessed Tax of $3.32 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-06
- Alector, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $3.32M, a 57.84% decline year-over-year.
- Alector, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $1.05M, a 71.53% decline year-over-year.
- Alector, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $6.24M, a 88.50% decline year-over-year.
- Alector, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $3.26M, a 78.75% decline year-over-year.
- Alector, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $21.05M, a 79.07% decline from fiscal 2024.
- Alector, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $100.56M, a 3.60% increase from fiscal 2023.
- Alector, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $97.06M, a 27.36% decline from fiscal 2022.
- Alector, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $133.62M, a 35.48% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.32M 10-Q · filed 2026-08-06 | $4.37M 10-Q · filed 2026-08-06 | $10.60M derived: sum of 3 quarters · filed 2026-08-06 | $13.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.05M 10-Q · filed 2026-05-07 | $7.28M derived: sum of 2 quarters · filed 2026-05-07 | $10.54M derived: sum of 3 quarters · filed 2026-05-07 | $18.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $9.50M derived: sum of 2 quarters · filed 2026-02-25 | $17.37M derived: sum of 3 quarters · filed 2026-08-06 | $21.05M 10-K · filed 2026-02-25 |
| 2025-09-30 | $3.26M 10-Q · filed 2025-11-06 | $11.13M derived: sum of 2 quarters · filed 2026-08-06 | $14.81M 10-Q · filed 2025-11-06 | $69.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.87M 10-Q · filed 2026-08-06 | $11.55M 10-Q · filed 2026-08-06 | $65.79M derived: sum of 3 quarters · filed 2026-08-06 | $81.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.67M 10-Q · filed 2026-05-07 | $57.91M derived: sum of 2 quarters · filed 2026-05-07 | $73.26M derived: sum of 3 quarters · filed 2026-05-07 | $88.34M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $54.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $69.58M derived: sum of 2 quarters · filed 2026-02-25 | $84.67M derived: sum of 3 quarters · filed 2026-02-25 | $100.56M 10-K · filed 2026-02-25 |
| 2024-09-30 | $15.34M 10-Q · filed 2025-11-06 | $30.43M derived: sum of 2 quarters · filed 2025-11-06 | $46.32M 10-Q · filed 2025-11-06 | $61.51M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $15.08M 10-Q · filed 2025-08-07 | $30.98M 10-Q · filed 2025-08-07 | $46.17M derived: sum of 3 quarters · filed 2025-08-07 | $55.27M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $15.89M 10-Q · filed 2025-05-08 | $31.08M derived: sum of 2 quarters · filed 2025-05-08 | $40.19M derived: sum of 3 quarters · filed 2025-05-08 | $96.41M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $15.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $24.30M derived: sum of 2 quarters · filed 2025-02-26 | $80.51M derived: sum of 3 quarters · filed 2025-02-26 | $97.06M 10-K · filed 2025-02-26 |
| 2023-09-30 | $9.11M 10-Q · filed 2024-11-06 | $65.32M derived: sum of 2 quarters · filed 2024-11-06 | $81.87M 10-Q · filed 2024-11-06 | $96.31M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $56.21M 10-Q · filed 2024-08-07 | $72.76M 10-Q · filed 2024-08-07 | $87.20M derived: sum of 3 quarters · filed 2025-02-26 | $102.06M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $16.55M 10-Q · filed 2024-05-08 | $30.99M derived: sum of 2 quarters · filed 2025-02-26 | $45.84M derived: sum of 3 quarters · filed 2025-02-26 | $125.69M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $14.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $29.29M derived: sum of 2 quarters · filed 2025-02-26 | $109.14M derived: sum of 3 quarters · filed 2025-02-26 | $133.62M 10-K · filed 2025-02-26 |
| 2022-09-30 | $14.85M 10-Q · filed 2023-11-07 | $94.70M derived: sum of 2 quarters · filed 2023-11-07 | $119.18M 10-Q · filed 2023-11-07 | $133.17M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $79.85M 10-Q · filed 2023-08-03 | $104.33M 10-Q · filed 2023-08-03 | $118.32M derived: sum of 3 quarters · filed 2024-02-27 | $300.73M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $24.47M 10-Q · filed 2023-05-04 | $38.47M derived: sum of 2 quarters · filed 2024-02-27 | $220.88M derived: sum of 3 quarters · filed 2024-02-27 | $227.45M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $13.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $196.41M derived: sum of 2 quarters · filed 2024-02-27 | $202.97M derived: sum of 3 quarters · filed 2024-02-27 | $207.09M 10-K · filed 2024-02-27 |
| 2021-09-30 | $182.41M 10-Q · filed 2022-11-08 | $188.98M derived: sum of 2 quarters · filed 2022-11-08 | $193.09M 10-Q · filed 2022-11-08 | $197.94M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $6.57M 10-Q · filed 2022-08-04 | $10.68M 10-Q · filed 2022-08-04 | $15.53M derived: sum of 3 quarters · filed 2023-02-28 | $21.43M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $4.11M 10-Q · filed 2022-05-05 | $8.96M derived: sum of 2 quarters · filed 2023-02-28 | $14.87M derived: sum of 3 quarters · filed 2023-02-28 | $18.04M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $10.76M derived: sum of 2 quarters · filed 2023-02-28 | $13.93M derived: sum of 3 quarters · filed 2023-02-28 | $21.10M 10-K · filed 2023-02-28 |
| 2020-09-30 | $5.90M 10-Q · filed 2021-11-04 | $9.07M derived: sum of 2 quarters · filed 2021-11-04 | $16.25M 10-Q · filed 2021-11-04 | $22.25M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $3.17M 10-Q · filed 2021-08-03 | $10.34M 10-Q · filed 2021-08-03 | $16.34M derived: sum of 3 quarters · filed 2022-02-24 | $19.04M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $7.17M 10-Q · filed 2021-05-05 | $13.17M derived: sum of 2 quarters · filed 2022-02-24 | $15.87M derived: sum of 3 quarters · filed 2022-02-24 | $22.79M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $8.70M derived: sum of 2 quarters · filed 2022-02-24 | $15.61M derived: sum of 3 quarters · filed 2022-02-24 | $21.22M 10-K · filed 2022-02-24 |
| 2019-09-30 | $2.70M 10-Q · filed 2020-11-10 | $9.61M derived: sum of 2 quarters · filed 2020-11-10 | $15.22M 10-Q · filed 2020-11-10 | $24.36M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $6.92M 10-Q · filed 2020-08-11 | $12.52M 10-Q · filed 2020-08-11 | $21.67M derived: sum of 3 quarters · filed 2021-02-25 | $28.17M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $5.61M 10-Q · filed 2020-05-13 | $14.75M derived: sum of 2 quarters · filed 2021-02-25 | $21.25M derived: sum of 3 quarters · filed 2021-02-25 | $28.36M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $15.65M derived: sum of 2 quarters · filed 2021-02-25 | $22.76M derived: sum of 3 quarters · filed 2021-02-25 | $27.51M 10-K · filed 2021-02-25 |
| 2018-09-30 | $6.50M 10-Q · filed 2019-11-12 | $13.61M derived: sum of 2 quarters · filed 2019-11-12 | $18.36M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $7.11M 10-Q · filed 2019-08-12 | $11.86M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $4.75M 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $2.87M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |